Literature DB >> 33253974

Prevalence and features of IOS-defined small airway disease across asthma severities.

Marcello Cottini1, Anita Licini2, Carlo Lombardi3, Alvise Berti4.   

Abstract

BACKGROUND: Impulse oscillometry (IOS) is a noninvasive method based on the forced oscillation technique able to detect small airway dysfunction (SAD) in asthma. We aimed to analyze the prevalence and the functional features of IOS-defined SAD across the different Global Initiative for Asthma (GINA) steps.
METHODS: A cross-sectional, single-center study in which 400 consecutive adult patients with physician-diagnosed, community-managed asthma underwent standard spirometry and IOS, and were stratified by stepwise GINA classification. SAD was defined by IOS as a fall in resistance from 5 to 20 Hz [R5-R20]>0.07kPa × s × L-1.
RESULTS: The prevalence of IOS-defined SAD ranged between 58.3% (GINA step 2) and 78.6% (GINA step 5), without statistically significant difference within GINA steps (p > 0.05 in all comparisons). Isolated SAD (i.e. without proximal airways involvement) was similarly represented across GINA steps 2-4. Peripheral airways resistance (R5-R20) tended to a progressive increase with the worsening of GINA steps, and was significantly higher in steps 4-5 compared to the other steps (p < 0.05). The proportion of patients with FEF25-75%-defined SAD (<60%) was lower than the IOS-defined one in GINA steps 2-4 (p < 0.05). Only non-significant or weak inverse correlations between R5-R20 and FEF25-75% were observed within each GINA step, with the exception of GINA step 5, which showed a strong, inverse correlation (r = -0.80, p = 0.0005).
CONCLUSIONS: This study shows that first, IOS-defined SAD is overwhelmingly present across asthma severities; second, airways resistance increases with the worsening of GINA steps; and third, SAD may be overlooked by standard spirometry, especially in milder asthma.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asthma; Community-treated asthma; IOS; Oscillometry; Small airways; Small airways dysfunction

Year:  2020        PMID: 33253974     DOI: 10.1016/j.rmed.2020.106243

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  3 in total

Review 1.  Small Airways: The "Silent Zone" of 2021 GINA Report?

Authors:  Marcello Cottini; Carlo Lombardi; Giovanni Passalacqua; Diego Bagnasco; Alvise Berti; Pasquale Comberiati; Gianluca Imeri; Massimo Landi; Enrico Heffler
Journal:  Front Med (Lausanne)       Date:  2022-05-23

Review 2.  Impulse Oscillometry, Small Airways Disease, and Extra-Fine Formulations in Asthma and Chronic Obstructive Pulmonary Disease: Windows for New Opportunities.

Authors:  Alfredo Chetta; Nicola Facciolongo; Cosimo Franco; Laura Franzini; Alessio Piraino; Carmelina Rossi
Journal:  Ther Clin Risk Manag       Date:  2022-10-01       Impact factor: 2.755

Review 3.  Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma.

Authors:  Carlo Lombardi; Marcello Cottini; Alvise Berti; Pasquale Comberiati
Journal:  Asthma Res Pract       Date:  2022-10-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.